PE20000413A1 - Ligandos azabiciclicos de receptores 5ht1 - Google Patents
Ligandos azabiciclicos de receptores 5ht1Info
- Publication number
- PE20000413A1 PE20000413A1 PE1999000270A PE00027099A PE20000413A1 PE 20000413 A1 PE20000413 A1 PE 20000413A1 PE 1999000270 A PE1999000270 A PE 1999000270A PE 00027099 A PE00027099 A PE 00027099A PE 20000413 A1 PE20000413 A1 PE 20000413A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- ring
- alcoxy
- isoxazol
- benzo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Luminescent Compositions (AREA)
Abstract
SE REFIERE A COMPUESTOS AZABICICLICOS AMINOMETILFENOXIMETIL/BENZOISOXAZOL SUSTITUIDOS DE FORMULA I, DONDE R3, R4 Y Z SON H, HALO, ALQUILO C1-C4, ALCOXI C1-C4, (ALCOXI C1-C4)(ALQUILO C1-C4); W ES -CH2-O-ALQUILO C1-C6, -CH2NR1R2; R1 Y R2 SON H, ALQUILO C1-C6, FORMAN UN MONOCICLO NO AROMATICO DE 4-7 MIEMBROS, ANILLO BICICLICO DE 7-10 MIEMBROS; CON LA CONDICION DE QUE EN CADA ANILLO FORMADO POR NR1R2 NO PUEDE HABER MAS DE 1 OXIGENO EN EL ANILLO, NO PUEDE HABER NINGUN HIDROXI, ALCOXI, ALCOXIMETILO, CIANO, AMINO, ALQUILAMINO, EL ANILLO NO PRESENTA INSATURACIONES. SON COMPUESTOS PREFERIDOS (7R,9aS)-TRANS-1-{3-[2-(5-FLUORO-BENZO[d]ISOXAZOL-3-IL)-OCTAHIDROPIRIDO[1,2-a]PIRAZIN-7-ILMETOXI]-BENCIL}-AZETIDIN-3-OL, (7R,9aS)-TRANS-2-(5-FLUORO-BENZO[d]ISOXAZOL-3-IL)-7-(3-MORFOLIN-4-ILMETILFENOXIMETIL)-OCTAHIDRO-PIRIDO[1,2-a]PIRAZINA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICON QUE COMPRENDE ADEMAS UN INHIBIDOR DE LA RECAPTACION DE 5-HT TAL COMO SERTRALINA O UN ANTAGONISTA O AGONISTA DE 5-HT1. EL COMPUESTO I MODULA LA NEUROTRANSMISION SEROTONERGICA, PUDIENDO SER UN ANTAGONISTA O AGONISTA DEL RECEPTOR DE SEROTONINA 5-HT1D Y PUEDE SER UTIL PARA EL TRATAMIENTO DE HIPERTENSION, DEPRESION, MIGRANA, TRASTORNOS DE ANSIEDAD GENERALIZADA, FOBIAS, SINDROME DE ESTRES POST-TRAUMATICO, TRASTORNO DE ANULACION DE PERSONALIDAD
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8123798P | 1998-04-09 | 1998-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20000413A1 true PE20000413A1 (es) | 2000-05-25 |
Family
ID=22162936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000270A PE20000413A1 (es) | 1998-04-09 | 1999-04-05 | Ligandos azabiciclicos de receptores 5ht1 |
Country Status (41)
| Country | Link |
|---|---|
| US (2) | US6525048B1 (es) |
| EP (1) | EP1070065B1 (es) |
| JP (1) | JP3496759B2 (es) |
| KR (1) | KR100378931B1 (es) |
| CN (1) | CN1117092C (es) |
| AP (1) | AP1175A (es) |
| AR (1) | AR015751A1 (es) |
| AT (1) | ATE248838T1 (es) |
| AU (1) | AU749254B2 (es) |
| BG (1) | BG104915A (es) |
| BR (1) | BR9909522A (es) |
| CA (1) | CA2327782A1 (es) |
| CO (1) | CO5080727A1 (es) |
| CZ (1) | CZ20003684A3 (es) |
| DE (1) | DE69910997T2 (es) |
| DK (1) | DK1070065T3 (es) |
| DZ (1) | DZ2756A1 (es) |
| EA (1) | EA003400B1 (es) |
| ES (1) | ES2204154T3 (es) |
| HK (1) | HK1035719A1 (es) |
| HR (1) | HRP20000653A2 (es) |
| HU (1) | HUP0102400A3 (es) |
| ID (1) | ID26086A (es) |
| IL (1) | IL138629A0 (es) |
| IS (1) | IS5641A (es) |
| MA (1) | MA26619A1 (es) |
| MY (1) | MY133390A (es) |
| NO (1) | NO20005004L (es) |
| NZ (1) | NZ507010A (es) |
| OA (1) | OA11496A (es) |
| PA (1) | PA8469101A1 (es) |
| PE (1) | PE20000413A1 (es) |
| PL (1) | PL343408A1 (es) |
| PT (1) | PT1070065E (es) |
| SK (1) | SK14782000A3 (es) |
| TN (1) | TNSN99056A1 (es) |
| TR (1) | TR200002932T2 (es) |
| TW (1) | TW555758B (es) |
| WO (1) | WO1999052907A1 (es) |
| YU (1) | YU59400A (es) |
| ZA (1) | ZA992596B (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6231833B1 (en) * | 1999-08-05 | 2001-05-15 | Pfizer Inc | 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors |
| UA62015C2 (en) * | 1998-12-28 | 2003-12-15 | Pfizer Prod Inc | Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants) |
| BR0014166A (pt) * | 1999-09-03 | 2002-05-14 | Lilly Co Eli | Método de utilização de inibidores de reabsorção de serotonina seletivo de rápido ataque para tratamento de disfunção sexual |
| GB2362826A (en) * | 2000-06-02 | 2001-12-05 | Lilly Co Eli | A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist |
| US6855729B2 (en) * | 2001-02-20 | 2005-02-15 | Timothy G. Dinan | Treatment of fibromyalgia and related fatigue syndromes using antagonists or partial agonists of 5HT1a receptors |
| OA13038A (en) * | 2003-03-12 | 2006-11-10 | Pfizer Prod Inc | Pryridyloxymethyl and benzisoxazole azabicyclic derivatives. |
| CA2555172A1 (en) * | 2004-01-29 | 2005-09-09 | Pfizer Products Inc. | Combinations of an atypical antipsychotic and an aminomethylpyridyloxymethyl/benzisoxazole azabicyclic derivatives for treating cns disorders |
| JP4559749B2 (ja) * | 2004-02-16 | 2010-10-13 | あすか製薬株式会社 | ピペラジニルピリジン誘導体 |
| AR048112A1 (es) * | 2004-03-25 | 2006-03-29 | Solvay Pharm Bv | Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor |
| AR049478A1 (es) | 2004-03-25 | 2006-08-09 | Solvay Pharm Bv | Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas. |
| CA2571555A1 (en) * | 2004-06-22 | 2006-01-05 | Pfizer Products Inc. | Diazabicyclic histamine-3 receptor antagonists |
| EP2248524A3 (en) | 2004-08-25 | 2011-03-09 | Takeda Pharmaceutical Company Limited | Preventives/remedies for stress urinary incontinence and method of screening the same |
| WO2006027692A2 (en) * | 2004-09-10 | 2006-03-16 | Pfizer Products Inc. | Methods of treating cognitive disorders using pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5106849A (en) * | 1988-05-24 | 1992-04-21 | American Home Products Corporation | Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders |
| WO1990008148A1 (en) * | 1989-01-23 | 1990-07-26 | Pfizer Inc. | Bis-aza-bicyclic anxiolytic agents |
| US5157034A (en) * | 1991-02-27 | 1992-10-20 | Pfizer Inc. | Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines |
| HUT71488A (en) * | 1991-09-25 | 1995-11-28 | Pfizer | Process for the production of neuroleptic 2-substituted perhydro-1-h-pyrido[1,2a]pyrazines and pharmaceuticals compositions containing the same |
| US5262428A (en) * | 1992-03-13 | 1993-11-16 | Wake Forest University | Biologically active tropane derivatives |
| DK0646116T3 (da) * | 1992-06-16 | 1999-12-27 | Pfizer | Fremgangsmåde og mellemprodukter til fremstilling af bis-aza-bicycliske anxiolytiske midler |
| GB9410512D0 (en) * | 1994-05-25 | 1994-07-13 | Smithkline Beecham Plc | Novel treatment |
| US5731307A (en) * | 1994-09-30 | 1998-03-24 | Pfizer, Inc. | Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines |
| US5614523A (en) * | 1995-01-17 | 1997-03-25 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
-
1999
- 1999-03-17 PA PA19998469101A patent/PA8469101A1/es unknown
- 1999-03-18 DE DE69910997T patent/DE69910997T2/de not_active Expired - Fee Related
- 1999-03-18 EA EA200000910A patent/EA003400B1/ru not_active IP Right Cessation
- 1999-03-18 AT AT99945686T patent/ATE248838T1/de not_active IP Right Cessation
- 1999-03-18 PT PT99945686T patent/PT1070065E/pt unknown
- 1999-03-18 PL PL99343408A patent/PL343408A1/xx not_active Application Discontinuation
- 1999-03-18 CN CN99807195A patent/CN1117092C/zh not_active Expired - Fee Related
- 1999-03-18 JP JP2000543464A patent/JP3496759B2/ja not_active Expired - Fee Related
- 1999-03-18 SK SK1478-2000A patent/SK14782000A3/sk unknown
- 1999-03-18 TR TR2000/02932T patent/TR200002932T2/xx unknown
- 1999-03-18 IL IL13862999A patent/IL138629A0/xx unknown
- 1999-03-18 HU HU0102400A patent/HUP0102400A3/hu unknown
- 1999-03-18 AU AU32687/99A patent/AU749254B2/en not_active Ceased
- 1999-03-18 WO PCT/IB1999/000457 patent/WO1999052907A1/en active IP Right Grant
- 1999-03-18 NZ NZ507010A patent/NZ507010A/en unknown
- 1999-03-18 ES ES99945686T patent/ES2204154T3/es not_active Expired - Lifetime
- 1999-03-18 DK DK99945686T patent/DK1070065T3/da active
- 1999-03-18 BR BR9909522-0A patent/BR9909522A/pt not_active Application Discontinuation
- 1999-03-18 US US09/403,892 patent/US6525048B1/en not_active Expired - Fee Related
- 1999-03-18 KR KR10-2000-7011167A patent/KR100378931B1/ko not_active IP Right Cessation
- 1999-03-18 YU YU59400A patent/YU59400A/sh unknown
- 1999-03-18 CZ CZ20003684A patent/CZ20003684A3/cs unknown
- 1999-03-18 EP EP99945686A patent/EP1070065B1/en not_active Expired - Lifetime
- 1999-03-18 ID IDW20002017A patent/ID26086A/id unknown
- 1999-03-18 CA CA002327782A patent/CA2327782A1/en not_active Abandoned
- 1999-04-02 TW TW088105301A patent/TW555758B/zh not_active IP Right Cessation
- 1999-04-05 PE PE1999000270A patent/PE20000413A1/es not_active Application Discontinuation
- 1999-04-07 MY MYPI99001344A patent/MY133390A/en unknown
- 1999-04-07 DZ DZ990057A patent/DZ2756A1/xx active
- 1999-04-07 MA MA25527A patent/MA26619A1/fr unknown
- 1999-04-07 TN TNTNSN99056A patent/TNSN99056A1/fr unknown
- 1999-04-07 AR ARP990101572A patent/AR015751A1/es unknown
- 1999-04-08 AP APAP/P/1999/001502A patent/AP1175A/en active
- 1999-04-08 ZA ZA9902596A patent/ZA992596B/xx unknown
- 1999-04-09 CO CO99021093A patent/CO5080727A1/es unknown
-
2000
- 2000-09-26 IS IS5641A patent/IS5641A/is unknown
- 2000-10-04 NO NO20005004A patent/NO20005004L/no not_active Application Discontinuation
- 2000-10-04 HR HR20000653A patent/HRP20000653A2/hr not_active Application Discontinuation
- 2000-10-06 OA OA1200000273A patent/OA11496A/en unknown
- 2000-11-07 BG BG104915A patent/BG104915A/xx unknown
-
2001
- 2001-09-04 HK HK01106215A patent/HK1035719A1/xx not_active IP Right Cessation
-
2003
- 2003-02-11 US US10/364,804 patent/US6887905B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20000413A1 (es) | Ligandos azabiciclicos de receptores 5ht1 | |
| MX2007013021A (es) | Derivados de benzofuranil-alcanamina y usos de los mismos como agonistas de 5-ht2c. | |
| CO5550421A2 (es) | Derivados de indol utiles para el tratamiento de enfermeda- des | |
| UY26020A1 (es) | Inhibidores de la recaptacion de monoaminas para el tratamiento de trastornos del snc. | |
| PE20010574A1 (es) | Derivados de indol como ligandos del receptor 5-ht2 | |
| PE20040937A1 (es) | Derivados de piridazin-3(2h)-ona como inhibidores de fosfodiesterasa-4 (pde 4) | |
| BR9406481A (pt) | Derivados de indol como agonistas do tipo 5-HT1 para utilização na enxaqueca | |
| PE20051054A1 (es) | Compuestos heterociclicos utiles como secretagogos de la hormona de crecimiento | |
| PE20070093A1 (es) | Derivados dihidrobenzofuranos como moduladores del receptor 5-ht2c | |
| TW200718692A (en) | Dihydrobenzofuran derivatives and uses thereof | |
| DE602004006165D1 (de) | Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors | |
| ES2161231T3 (es) | Compuestos heterociclicos como antagonistas de bradiquinina. | |
| PE20040832A1 (es) | Derivados de indolil pirazinona | |
| MX2007005199A (es) | Indolizinas sustituidas y derivados como agentes del sistema nervioso central. | |
| PE20081316A1 (es) | COMPUESTOS HETEROCICLICOS QUE MODULAN LA ACTIVIDAD DE LA ESTEROIL-CoA-DESATURASA | |
| CR9690A (es) | 3-acilaminobenzanilidas insecticidas | |
| BRPI0516467A (pt) | derivados indol 5-sulfonil-1-piperidinil substituìdos como antagonistas de receptor de 5-ht6 para o tratamento de distúrbios do snc | |
| ES2188957T3 (es) | N-(4-(heteroarilmetil)fenil)-heteroarilaminas. | |
| CL2009000404A1 (es) | Compuestos derivados de piperidin-indol-sustituidos, moduladores de receptores nociceptina/orl1; proceso de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades del snc, cardiovasculares, metabolicas, entre otras. | |
| PL1831152T3 (pl) | Pochodne tetraliny i indanu oraz ich zastosowanie jako antagonistów 5-HT | |
| SI1506185T1 (sl) | Spojine in njihova uporaba kot inhibitorji 5-HT | |
| PE20011030A1 (es) | Combinaciones farmaceuticas que comprenden tegaserod y omeprazol | |
| AR009413A1 (es) | Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende | |
| ECSP088967A (es) | Agonistas del receptor muscarínico que son efectivos en el tratamiento del dolor, la enfermedad de alzheimer y la esquizofrenia | |
| PE20030610A1 (es) | Derivados de 3-azabiciclo[3.1.0]hexano con afinidad a los receptores opioides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |